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Our view of the RNA polymerase III (Pol III) transcription machinery in mammalian cells arises mostly from studies of
the RN5S (5S) gene, the Ad2 VAI gene, and the RNU6 (U6) gene, as paradigms for genes with type 1, 2, and 3 promoters.
Recruitment of Pol III onto these genes requires prior binding of well-characterized transcription factors. Technical lim-
itations in dealing with repeated genomic units, typically found at mammalian Pol III genes, have so far hampered genome-
wide studies of the Pol III transcription machinery and transcriptome. We have localized, genome-wide, Pol III and some of
its transcription factors. Our results reveal broad usage of the known Pol III transcription machinery and define a minimal
Pol III transcriptome in dividing IMR90hTert fibroblasts. This transcriptome consists of some 500 actively transcribed
genes including a few dozen candidate novel genes, of which we confirmed nine as Pol III transcription units by additional
methods. It does not contain any of the microRNA genes previously described as transcribed by Pol III, but reveals two other
microRNA genes, MIR886 (hsa-mir-886) and MIR1975 (RNY5, hY5, hsa-mir-1975), which are genuine Pol III transcription units.
[Supplemental material is available online at http://www.genome.org. The sequencing data from this study have been
submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE18184.]
Three main RNA polymerases transcribe the nuclear genome in
mammalian cells. RNA polymerase (Pol) I transcribes the large ri-
bosomal RNAs; Pol II the mRNA-coding genes, some small nuclear
(snRNA) genes, and regulatory RNA genes such as microRNA
genes; and Pol III transcribes a number of noncoding RNA genes
whose products are involved in fundamental cellular processes,
such as protein synthesis, RNA processing, transcription and
chromatin regulation, and in some still poorly defined functions
(Schramm and Hernandez 2002; Dieci et al. 2007). Pol III tran-
scription is regulated with cell growth and proliferation, and in
response to stress (for review, see White 2005; Goodfellow and
White 2007). Deregulation of Pol III is linked to diseases such as
Alzheimer’s disease, fragile X syndrome, and cancer (for review, see
White 2008). Indeed, not only has it been shown that tumor
suppressors inhibit Pol III activity, overexpression of a tRNA Met
initiator gene is sufficient to cause oncogenic transformation of
mouse embryo fibroblasts (Marshall et al. 2008).
Despite the essential role of Pol III, our knowledge of the Pol
III transcription machinery relies largely on biochemical studies
performed on essentially three model genes with type 1, 2, and 3
promoters, namely the RN5S (5S), Adenovirus 2 VAI, and mam-
malian RNU6 (U6) snRNA genes, respectively. As summarized in
Figure 1, the internal control region (ICR) of the type 1 5S promoter
binds the zinc finger protein TFIIIA. This leads to recruitment of
the TFIIIC complex and BRF1–TFIIIB, a factor composed of the
TATA box binding protein TBP, the SANT domain protein BDP1,
and the TFIIB-related factor BRF1. In contrast, the A and B boxes
of the type 2 VAI promoter bind TFIIIC directly, leading to re-
cruitment of BRF1–TFIIIB. In type 3 promoters, the proximal se-
quence element (PSE) and TATAbox that constitute the core region
bind, respectively, the snRNA activating protein complex SNAPc
and the TBP component of a variant of TFIIIB, BRF2–TFIIIB. BRF2–
TFIIIB differs from BRF1–TFIIIB by the replacement of BRF1 with
BRF2 (see Schramm and Hernandez 2002). A large scale chromatin
immunoprecipitation followed by analysis on a DNA array carry-
ing about 1000 genomic fragments enriched in promoter se-
quences (ChIP-on-chip) revealed co-occupancy of many Pol III
promoters by BRF1, BDP1, and Pol III, suggesting a wide use of
these factors in human cells (Denissov et al. 2007). Nevertheless,
how broadly this machinery is used in the entire mammalian
genome remains to be determined.
Another important question is the extent of the Pol III tran-
scriptome. In yeast, ChIP-on-chip studies have defined the yeast Pol
III transcriptome as consisting of all tRNA genes and a few addi-
tional RNA genes (Harismendy et al. 2003; Roberts et al. 2003;
Moqtaderi and Struhl 2004). At all these genes, binding of Pol III
correlates with gene activity as measured by RNA levels. In Dro-
sophila Schneider line 2 (S2) cells, a recent analysis has identified 359
BRF1 and 354 TRF1 (which replaces TBP in Drosophila TFIIIB) ge-
nomic binding sites, correspondingmostly to tRNA genes, as well as
to other RNA genes such as the RN7SL1 (7SL) RNA gene and some
snoRNA genes (Isogai et al. 2007). In mammalian cells, genome-
wide studies have been limited by the lack of a technology to study
repeated sequences. Nevertheless, several reports indicate that Pol
III may synthesize more RNAs than previously suspected, including
microRNAs (Borchert et al. 2006; Ozsolak et al. 2008) and putative
new Pol III genes with type 3 promoters (Pagano et al. 2007; see
Dieci et al. 2007). Here we have combined the recently developed
ChIP-seq method (genome-wide ChIP followed by ultrahigh
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throughput sequencing of the immunoprecipitatedmaterial) with
a bioinformatics analysis tailored to deal with repeated sequences
to address (1) the generality of the known human Pol III tran-
scription machinery usage and (2) the extent of the Pol III tran-
scriptome, in exponentially growing human IMR90hTert cells.
Results
Localization of POLR3D (RPC4), BDP1, BRF1, and SNAPC2
(SNAP45) in the genome of exponentially growing
IMR90hTert cells
Chromatin from IMR90hTert lung fibroblasts, an immortal cell
line stably transfected with human telomerase reverse transcrip-
tase, was crosslinked in intact cells, sonicated, and subjected to
immunoprecipitation. To identify actively transcribed Pol III tran-
scription units, we used antibodies directed against the POLR3D
(RPC4) subunit of Pol III. To identify promoter regions, we used
antibodies against BDP1, a hallmark of all three types of promoters,
and BRF1, a hallmark of type 1 and 2 promoters (see Fig. 1). For
gene-external promoters, we engineered an IMR90hTert cell line
expressing the SNAPc subunit SNAPC2 (SNAP45) tagged at its
C terminus with the biotin acceptor domain, as well as the biotin
ligase BirA (Mito et al. 2005), and performed chromatin affinity
purification (ChAP) with streptavidin beads.
The precipitated material was then processed for deep se-
quencing, whose output is millions of short sequences, referred to
as tags (see Supplemental Table S1). Such tags were then mapped
onto the genome assembly (UCSC HG18), before being used for
peak detection and quantification. In the case of Pol III, tag map-
ping must take into account large families of highly related genes
and pseudogenes. For instance, alignment analyses (BLAT) of RN5S
genes reveal 982 related sequences in the human genome. Com-
monly used methods do not provide a proper solution to this
problem in that they (1) use the masked genome assembly from
which all repeated sequences are excluded, (2) eliminate tags
matching at more than two locations in the genome, and (3) allow
up to two sequencemismatches in the alignment of the tags to the
genome. Therefore, we devised a custom protocol for analysis of
the data, which is described in the Supplementalmaterial. First, we
used a partially unmasked genome, which gave us access to re-
peated sequences. Second, alignment of the tags (35 nucleotides
[nt] except for the SNAPC2 experiment, in which we obtained
75-nt tag reads) was performed with the ‘‘fetchGWI’’ software
(http://www.isrec.isb-sib.ch/tagger/; Iseli et al. 2007), which al-
lowed us to align tags withmultiplematches in the genome. Third,
we aligned only tags with a perfect sequence match, which opti-
mized the ability to attribute a tag to the correct genomic location
among highly related sequences. Fourth, for peak detection and
quantification, we took into account both unique and repeated
tags, as described in the Supplemental material.
Figure 2 showsUCSC Browser views of three Pol III genes with
POLR3D peaks. Figure 2A is an example of a POLR3D peak con-
stituted almost exclusively (99.7%) of tags with uniquematches in
the genome, which map to a tRNALeu-TAG gene, TRNAU1. The
upper track shows the unique tag component and the lower track
the combination of unique and repeated tag components. The
third track, labeled ‘‘unique match coverage,’’ is represented by
a black bar and indicates the DNA regions covered by tags unique
within all POLR3D peaks in the genome. In this case, the black bar
covers the entire peak region, illustrating that the entire peak
width is covered with unique tags (note that the tags are unique
within POLR3D peaks and not within the entire genome, as evi-
denced by the UCSC annotation at the bottom of Figure 2A,
showing that part of the peak corresponds to an element repeated
in the genome). Consequently, the resulting peaks are identical.
Figure 2B is an example with both unique and repeated tags
mapping to a RN7SK (7SK) gene. In this case, the unique tag
component is represented by two peaks, corresponding to the 59
and 39 ends of the RNA-coding sequence, and matched by the
unique match coverage track. The combination of unique and
repeated tag components results in a continuous peak encom-
passing the gene. This pattern is consistent with the presence, in
the genome, of a number of RN7SK pseudogenes that probably
arose by retrotransposition and have, therefore, similar RNA-cod-
ing sequences, but divergent flanking sequences. Figure 2C shows
an example of a peak composed only of repeated tag reads. It maps
to a RN5S gene belonging to a cluster of repeated RN5S genes on
chromosome 1; thus, there is no unique tag component in the
upper track, and no signal for the unique match coverage track.
However, the repeated tag reads form a peak covering the RN5S-
coding region. Therefore, in this case, our procedure allowed
identification of a gene that would have been missed by a pro-
cedure excluding repeated tags. On the other hand, the procedure
only allows for approximate quantification, as repeated tags can-
not be allocated with absolute certainty to the correct location.
As shown in Supplemental Table S2, the above analysis pro-
duced 2169 POLR3D peaks, 1843 BDP1 peaks, and 6353 BRF1
peaks. Peaks found in the input control as well as satellite se-
quences, simple repeats, and 28S or 18S sequences and related se-
quences were excluded from our analysis. We chose to avoid the
use of stringent filters at this stage, reasoning that wemight be able
to eliminate noise more specifically by focusing on a combination
of peaks containing, at a minimum, a POLR3D peak and either a
BDP1 or a BRF1 peak.
POLR3D, BDP1, and BRF1 occupancies mark known Pol III genes
We first examined the location of POLR3D peaks relative to BDP1
and BRF1 peaks, as shown in Table 1. POLR3D peaks were close to
Figure 1. Three types of Pol III promoters and corresponding tran-
scription factors. (A–C ) Structures of types 1, 2, and 3 promoters, re-
spectively, as well as the factors they recruit.
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both BDP1 and BRF1 peaks in 362 cases,
and close to BRF1 or BDP1 peaks in 173
and 174 cases, respectively. To identify
genes associated with these peaks, we
used the annotations in the variousUCSC
tables and performed BLAT searches with
each known class of Pol III genes to
identify any nonannotated genomic se-
quences resembling them. The resulting
genes were divided into four categories as
shown in Table 1. The largest category
corresponded to tRNA genes, followed by
a second category containing some RNA
genes (e.g., RPPH1 [RNase P] and RMRP
[RNase MRP] genes) and microRNAs, a
third category containing the RN5S or
RN5S-related sequences, and a fourth
category containing Pol II genes (RefSeq
genes), Alu repeats, mitochondrial tRNA-
derived sequences, and L1 repeats. We
started our analysis with the tRNA genes,
as this gene family is exceptionally well
annotated.
Location of BDP1, BRF1, and POLR3D
peaks on tRNA genes
Figure 3A shows a UCSC Genome
Browser view of a 600,000-base pair (bp)
region of chromosome 6 with a large
number of tRNA genes, most of which are
associatedwith BDP1, BRF1, and POLR3D
peaks. Figure 3B shows a zoom-in on just
two tRNA genes. In both cases, POLR3D
peaks cover the whole RNA-coding se-
quence, whereas BDP1 and BRF1 peaks
are located upstream. The peak scores are
lower for the gene on the right, indicating
lower occupancy. Additionally, we no-
ticed that the BDP1 peaks were shifted
further upstream of the transcription
start site (TSS) than the BRF1 peaks. Figure
3C shows a plot of peak maxima density
relative to TSSs for all tRNA genes dis-
playing BDP1, BRF1, and POLR3D peaks.
Most BDP1 peakmaximawere at position
27, against position 14 for BRF1. This
suggests that within the BRF1–TFIIIB
complex, BDP1 contacts DNA slightly
upstream of BRF1, consistent with obser-
vations in yeast revealing BDP1 cross-
linking mostly upstream of BRF1 on the
59 flanking regions of tRNA genes (for
review, see Hernandez 2001). Thus, we
can use the chromatin immunoprecipi-
tation with themassively parallel sequenc-
ing (ChIP-seq) method to map protein–
DNA contacts at high resolution, and we
observe that on tRNA genes the BDP1 and
BRF1 peak maxima are located within the
59 flanking region of the genes, largely
upstream of the POLR3D peak.
Figure 2. Examples of POLR3D peaks with various proportions of unique and repeated tags. (A–C )
UCSC Genome Browser views of the indicated genomic locations. In each case, the upper track labeled
‘‘unique’’ shows the peak obtained with only the unique tag component of the peak shown in the
second track, labeled ‘‘all,’’ which contains all tags. The y-axis indicates cumulated tag weights. The
track labeled ‘‘unique match coverage’’ shows the regions spanned by tags unique within all POLR3D
peaks. Below the unique match coverage, UCSC Browser annotations for RNA genes and repeats from
RepeatMasker are shown. The visual peak tracks were generated as described in the legend to Figure 3.
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Many tRNA genes display low or no BDP1, BRF1,
and POLR3D occupancy
The human genome contains 522 predicted tRNA genes and 109
pseudogenes, as annotated by tRNAScan-SE (Lowe and Eddy 1997;
Schattner et al. 2005). Of these 631 genes and pseudogenes, 622
have beenmapped onto the genome (see http://gtrnadb.ucsc.edu/
Hsapi/). Supplemental Table S3 shows these 622 genes and pseudo-
genes together with their chromosome position, the positions and
scores (see below) of the A and B boxes, and the corresponding
POLR3D, BDP1, and BRF1 peaks and scores. The genes are sorted by
value of the POLR3D peak scores, ranging from 811 to 0.
To evaluate whether POLR3D peak scores reflect transcrip-
tional activity, we measured RNA levels for a few tRNA genes by
RT-qPCR.Wemeasured intron-containing tRNA precursors because
they are short-lived and, therefore, likely to better reflect ongoing
transcriptional activity than mature tRNAs that may have very dif-
ferent stabilities. We analyzed three pairs of precursor tRNAs and as
shown in Table 2, we consistently detected more precursor tRNAs
for genes with high POLR3D occupancy compared to genes with
low or undetectable POLR3D. This suggests that the POLR3D scores
reflect, at least to some extent, gene transcriptional activity.
We then examined the genes in Supplemental Table S3 and
divided them into four groups according to the POLR3D scores, as
summarized in Table 3. In the first class, containing the genes with
POLR3D scores greater than 269, there were no predicted pseudo-
genes and the large majority of the genes had corresponding BDP1
and BRF1 peaks (93.4% for BDP1 and 97.5% for BRF1). These
percentages were still high in the second class of genes with
POLR3D scores from 165 to 269, with 76.9% and 90.7% of the
genes also containing BDP1 and BRF1 peaks, respectively. This
second class contains two predicted pseudogenes; the first (row
122 in Supplemental Table S3) has a BRF1 peak but no BDP1 peak,
indeed the number of BDP1 tags in this region is just below the
cutoff for peak detection; the second (row 193 in Supplemental
Table S3) has clear POLR3D, BDP1, and BRF1 peaks. In both cases,
the BDP1 and/or BRF1 peaks are upstream of the POLR3D peak
(data not shown). It seems highly likely that these two pseudo-
genes are in fact expressed, raising the interesting question of the
function, if any, of the resulting RNAs. Note also the tRNA SeC(e)
gene TRNAU1 (row 138), which displays POLR3D and BDP1 peaks
but no BRF1 peak. As discussed further below, this gene displays
a SNAPC2 peak and is, therefore, expected to recruit BRF2 rather
than BRF1. In the third class, containing genes with POLR3D
scores from 3 to 165, 24.4% of the genes also displayed BDP1, and
49.4% also BRF1, peaks. This class con-
tains eight pseudogenes, none of which
with BDP1 or BRF1 peaks, suggesting that
they are weakly or not transcribed. The
fourth class contains 217 genes with no
POLR3D peaks, of which 99 are predicted
pseudogenes, indicating that the large
majority of predicted pseudogenes are not
expressed. None of the genes in this class
have BDP1 or BRF1 peaks except for one,
with the second lowest score BDP1 peak.
Thus, at least for tRNA genes, the presence
of BDP1 and/or BRF1 is a strong indicator
that the gene is also occupied by POLR3D
and thus probably transcribed, suggesting
that isolated BDP1 or BRF1 peaks else-
where in the genome do not mark active
Pol III transcription units. On the other hand, several tRNA genes
displaying POLR3D occupancy show no BDP1 and/or BRF1. The
large majority of these genes have, however, low POLR3D scores
(<50) suggesting that they are only veryweakly transcribed.Wenote
that among tRNA genes, BDP1 and BRF1 scores are, in almost all
cases, lower than POLR3D scores. The absence of BDP1 or BRF1
peaks on genes with low POLR3D score is thus consistent with
a lower sensitivity of our ChIPs for these two factors. Alternatively,
theremay exist tRNA genes with no Pol III transcription factors, but
with low levels of POLR3D, representing perhaps paused enzymes.
Distribution of isoacceptor tRNA genes in the groups
with high, medium, low, and no POLR3D occupancy
The annotated human tRNA genes and pseudogenes represent 52
different isoacceptor families (plus two families of suppressor tRNA
genes), potentially leading to expression of 52 different isoacceptor
tRNAs and two types of suppressors (http://gtrnadb.ucsc.edu/
Hsapi/). We examined POLR3D, BDP1, and BRF1 occupancy in
each isoacceptor family, and the results are summarized in Sup-
plemental Table S4. The large majority of isoacceptor families are
represented in groups 1 or 2, i.e., contain geneswith relatively high
POLR3D occupancy and accompanying BDP1 and BRF1 peaks,
suggesting expression. In contrast, the suppressor tRNA genes and
most pseudogenes fall in group 4 and are thus most likely not
expressed in dividing IMR90hTert cells. Curiously, in all families
containing three or fewer genes and pseudogenes (indicated in
purple in Supplemental Table S4), none of the genes harbors
convincing POLR3D, BDP1, and BRF1 peaks (the genes always fall
in group 4) with two exceptions: the Sec(TCA) genes, with one out
of three genes in group 2, and the Ser(ACT) pseudogene, which is
the only gene in its family and, asmentioned above, falls in group2.
tRNA genes with high POLR3D score have slightly different
A and B boxes than tRNA genes lacking POLR3D
Wewondered whether highly and not expressed tRNA genes might
differ in their A and B boxes. Supplemental Table S3 shows the lo-
cations and scores of the A and B boxes as determined with the
MEME motif search tool (Bailey and Elkan 1994). These scores do
not correlate well with POLR3D peak scores (data not shown),
suggesting that POLR3Doccupancy is dictated bymore factors than
just the sequence of the A and B boxes, such as, e.g., the spacing of
the boxes or elements in the 59 flanking sequence. Nevertheless,
Supplemental Figure S1 shows that the A and B box LOGO outputs
Table 1. Categories of genes with various combinations of POLR3D (RPC4), BRF1, and BDP1
Category














POLR3D (RPC4), BRF1, and BDP1 248 20 11 83 362
POLR3D (RPC4) and BRF1 only 75 7 2 89 173
POLR3D (RPC4) and BDP1 only 9 0 6 159 174
BDP1 and BRF1 peaks were grouped with POLR3D (RPC4) peaks when peak edges were within 60 and
50 nt, respectively, of each other. Peak groups were then assigned to a particular gene if an POLR3D
(RPC4) peak edge was within 100 nt of the start or end of an RNA-coding sequence, except for Alus and
other repeats, for which the distance had to be 0 nt.
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of MEME performed on (1) all tRNA genes/pseudogenes in Table
S3 (panel A), (2) the tRNA genes with POLR3D scores >400 (panel
B), and (3) the tRNA genes (but not the pseudogenes) with no
POLR3D (panel C), differ slightly. In the genes with the highest
POLR3D occupancy, the A box is extended by one position (1)
at the 59 end and shortened by one position at the 39 end, several
positions (T1, G3, A7, G11) become fixed, and a number of others
have higher information content. Similarly, a number of positions
in the B box become fixed (G6, T8, C9, A11, and C14) and others
gain in information content. Thus, the A and B box LOGOs for
genes with high POLR3D occupancy are the richest in information
and may reflect the strongest A and B box components for type 2
promoters.
Other genes with POLR3D, BDP1, and BRF1 peaks: RN5S genes
As shown in Table 1, the second category of genes with combina-
tions of POLR3D, BDP1, and BRF1 peaks corresponded to RN5S
genes. We found 982 5S or 5S-related sequences in the genome
assembly, either annotated or identified by BLAT searches. How-
ever, as shown in Table S5, only 20 5S sequences harbored
POLR3D, BDP1, and BRF1 peaks (rows 1–17, 20–22), and another
twohad POLR3Dand BRF1 peaks (rows 18, 19). Seventeen of these,
on chromosome 1, correspond to the previously described major
5S cluster on 1q42.11–q42.13 (Steffensen et al. 1974; Sorensen
et al. 1991; Stults et al. 2008). Figure 4A shows a UCSC Genome
Browser view of this cluster. Each annotated RN5S gene, as well as
Figure 3. Location of BDP1, BRF1, and POLR3D peaks on tRNA genes. (A) UCSCGenome Browser view of the indicated region of chromosome 6, which
contains a number of tRNA genes. The BRF1 and BDP1 visual peak tracks were generated from an overlap profile as described in Zhang et al. (2008). The
y-axis indicates cumulated tag weights. For the POLR3D visual track, the samemethod was used except that the tags were not extended to the actual size
of the sequenced fragments to prevent any artificial tag overlaps coming from adjacent peaks reflecting adjacent RNA polymerases. Below each of the
BRF1, BDP1, and POLR3D peaks, the uniquematch coverage is shown, indicating the regions spanned by tags uniquewithin the BRF1, BDP1, and POLR3D
peaks, respectively. (B) Zoom-in of a small region of chromosome 6. (C ) The density of peak maxima for all tRNA genes displaying BDP1, BRF1, and
POLR3D peaks was plotted relative to the TSSs.
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six additional RN5S sequences identified by BLAT located directly
upstream, display BDP1, BRF1, and POLR3Dpeaks, confirming that,
as shown previously in vitro, the 5S promoter recruits BRF1 rather
than BRF2 (Wang and Roeder 1995). Note that although these peaks
display an average occupancy quasi-identical due to their high se-
quence identity, some contain point mutations, which are reflected
in different peak scores. In contrast to the RN5S genes, two se-
quences annotated 5S RNA-like, located on either side of the cluster,
do not harbor POLR3D, BDP1, or BRF1 peaks. Figure 4B shows an
enlargement of one of the RN5S genes. Like for tRNA genes, the
BDP1 and BRF1 peak maxima are located upstream of the POLR3D
peak, although in this case the BDP1 and BRF1 peak maxima are
nearly coincident. This may reflect either a different BRF1 or BDP1
placement on type 1 promoters as compared to type 2 promoters, or
differences in crosslinking of these proteins due to the presence of
TFIIIA,whichmight shield or exposeBRF1 andBDP1protein surfaces.
Of the remaining five RN5S sequences in Supplemental Table
S5, two (rows 18 and 19) may be very weakly expressed; they have
low POLR3D and BRF1 peaks and lack a BDP1 peak, but the BRF1
peak is clearly located upstream of the TSS (data not shown). In
contrast, the other three (rows 20–22) display POLR3D, BDP1,
and BRF1 peaks, but these all have maxima inside the RN5S RNA-
coding sequence. As these three RN5S RNA-like sequences are very
divergent from the true RN5S genes outside of the RNA-coding
region, peaks reflecting BDP1 and BRF1 binding should contain
unique tags corresponding to the divergent 59 flanking region.
Thus, we suspect that these peaks represent noise generated by our
SISSRs (site identification from short sequence reads) analysis.
Other RNA genes and microRNAs
The third category of genes with combinations of POLR3D and
BDP1, POLR3D and BRF1, or POLR3D and both BDP1 and BRF1
peaks (see Table 1, category III) contained a number of known RNA
coding genes other than tRNA an RN5S genes. We first examined
those where the BRF1 peak was present, as genes lacking BRF1might
correspond to genes with type 3 promoters
(seeFig. 1).GeneswithBRF1peaks included
the vault RNA genes VTRNA1-1 (HVG-1),
VTRNA1-2 (HVG-2), and VTRNA1-3 (HVG-
3), which encode RNA components of the
large cytoplasmic vault particles implicated
in multidrug resistance (Kickhoefer et al.
1998), the genes RN7SL1, RN7SL2, and
RN7SL3 encoding the 7SL RNA component
of the signal recognition particle, a micro-
RNAgene, and the SNAR-A genes, as shown
in Supplemental Table S5. These genes are
discussed below.
The VTRNA1 (HVG) genes 1–3 differ
from the VTRNA1-4 gene by containing not only gene-internal A
and Bboxes, but also a TATAbox and another element located in the
59 flanking region (van Zon et al. 2001; Kickhoefer et al. 2003). Their
occupancy by POLR3D, BDP1, and BRF1 (rows 23–25), and the lack
of occupancy on the VTRNA1-4 gene, confirm that the 59 elements
are important for active transcription. Moreover, BRF1 recruitment
and the absence of a SNAPC2 peak (see below) show that they are
type 2 rather than type 3 genes, despite the TATA box in the 59
flanking region.
Among a large number of RN7SL-related sequences in the
genome, two true genes contain A and B boxes, as well as pro-
moter elements in the 59 flanking sequence (Ullu andWeiner 1985;
Bredow et al. 1990; Kickhoefer et al. 2003; Englert et al. 2004). We
found that these two genes (RN7SL1 and RN7SL2) indeed have
robust POLR3D, BDP1, and BRF1 peaks (rows 26, 27). In addition,
a third gene (RN7SL3, row 28) showed weak POLR3D and BRF1
peaks, but no BDP1 peak, suggesting that it is weakly transcribed.
There are two reports of microRNA genes transcribed by Pol III.
Ozsolak et al. (2008) describe a set of 11 microRNAs or microRNA
clusters occupied by Pol III or both Pol II and Pol III. We found
occupation of one of these, the hsa-mir-565 locus, by BDP1, BRF1,
and POLR3D, however, this locus (chr3:45704209–45706624)
corresponds, in fact, to a tRNA gene (see http://microrna.sanger.ac.
uk/cgi-bin/sequences/mirna_entry.pl?acc=MI0003571; Berezikov
et al. 2006). Similarly, we found BDP1, BRF1, and POLR3D on three
of the other listed chromosomal locations (chr16:14286104–
14288843, chr17:26900553–26902766, and chr7:138675183–
138677194), but these also correspond to tRNA genes. None of the
other microRNA loci displayed BDP1, BRF1, or POLR3D occupancy
in our analysis. Moreover, we noticed that several of these genes
contain internal runs of four or even five T residues, which serve as
termination signals for Pol III (Bogenhagen and Brown 1981). Thus,
these genes are not transcribed by Pol III in exponentially growing
IMR90hTert cells, and for someof themat least, it seemsunlikely that
they will be transcribed by Pol III in other cells (Bogenhagen and
Brown 1981). Borchert et al. 2006 identified a microRNA cluster on
Table 3. Separation of tRNA genes into four groups according to POLR3D (RPC4) peak scores
POLR3D (RPC4)
peak scores
No. of tRNA genes
(percent of total tRNA genes)
No. of predicted
pseudogenes
No. of tRNA genes
with a BDP1 peak
(percent of genes in
corresponding group)
No. of tRNA
genes with a BRF1
peak (percent of genes
in corresponding group)
>269 121 (19.5%) 0 113 (93.4%) 118 (97.5%)
>165–269 108 (17.4%) 2 83 (76.9%) 98 (90.7%)
>0–165 176 (28.3%) 8 43 (24.4%) 87 (49.4%)
No peak 217 (34.9%) 99 1 (0.5%) 0 (0%)
Table 2. qPCR quantitation of tRNA precursors derived from tRNA genes with different
POLR3D (RPC4) peak scores
tRNA isotype Genomic location
Peak scores
ERaPOLR3D (RPC4) BDP1 BRF1
tRNAArg-TCT chr9:130142175–130142267 17.63 0 0
3–4
tRNAArg-TCT chr17:7964967–7965056 190.6 27.3 77.0
tRNAIle-TAT chr6: 28613345–28613440 0 0 0
40–50
tRNAIle-TAT chr19:44594647–44594741 181.54 31.18 143.82
tRNAArg-TCT chr17:7964967–7965056 190.6 27.3 77
6–7
tRNATyr-GTA chr2:27127153–27127242 596.03 56.7 159.02
aExpression ratio of second over first precursor in each pair.
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chromosome 19 (58,860,000 to 58,960,000) with microRNAs syn-
thesized by Pol III from A and B boxes present in adjacent Alu se-
quences. Additionally, they identified other mir loci with putative
Pol III promoters. We did not observe any POLR3D, BDP1, or BRF1
peaks at the locations proposed, except in several cases where the
locus contains, in fact, a tRNA gene.
In contrast, we observed clear occupancy of a different
microRNA, MIR886 (hsa-mir-886) located on chromosome 5, by
BDP1, BRF1, and POLR3D, as illustrated in Figure 5A. This suggests
that MIR886 is strongly transcribed by
Pol III in IMR90hTert cells, and indeed, as
shown in Figure 5B, the DNA sequence
corresponding to the POLR3D peak con-
tains A and B boxes, as well as a run of T
residues, the termination site for Pol III.
We amplified a fragment of genomic DNA
containing the sequence occupied by Pol
III, as well as flanking sequences, immo-
bilized it on beads, and used it for tran-
scription in vitro. As control, we used
a fragment containing the Ad2 VAI gene.
As shown in Figure 5C, in vitro transcrip-
tionof theAd2VAI gene fragment gave rise
to the expected RNA product, whose syn-
thesis was sensitive to the Pol III-specific
inhibitor tagetin, as expected (Fig. 5C,
lanes 1, 2). Significantly, with the MIR886
DNA fragment, we obtained an RNA
whose size (;145 nt) and sensitivity to
tagetin were consistent with Pol III tran-
scription initiating and terminating as il-
lustrated in Figure 5B (Fig. 5C, lanes 3, 4). A
second, shorter fragment (;100 nt) may
correspond to partial processing of the
RNA. A Northern blot analysis of RNA
extracted from IMR90hTert cells revealed
an RNA of;100 nt, which corresponds to
the length of the predicted pre-miRNA (see
http://www.mirbase.org/cgi-bin/mirna_
entry.pl?acc=MI0005527) (Fig. 5D). Thus,
MIR886 is an example of a microRNA
genuinely transcribed by Pol III. As de-
scribed below (Supplemental Table S7), a
second example is that of the previously
described Pol III RNY5 (hY5) gene, which
turns out to overlapwith amicroRNAgene,
MIR1975 (hsa-mir1975).
The small NF90-associated RNA
(SNAR) genes encode RNAs associated
with NF90 (Parrott and Mathews 2007).
There are a number of SNAR genes, 14
SNAR-A, 2 SNAR-B, 5 SNAR-C, and an-
other seven slightly divergent SNAR
genes, all but two on chromosome 19.
The SNAR-As were shown to be tran-
scribed by Pol III in vitro from an in-
tragenic promoter, and indeed they con-
tain a B box (Parrott and Mathews 2007).
We observed relatively low POLR3D and
BRF1 peaks on all SNAR-A genes, but not
on any of the other SNAR genes. The BRF1
peaks were offset relative to the POLR3D
peak and upstream of the TSS, suggesting that these genes are in-
deed transcribed at a low level in IMR90hTert cells.
Other sequences with POLR3D, BDP1, and BRF1, or POLR3D
and BRF1, peaks reveal putative novel genes
An examination of the sequences in the fourth category of Table 1,
labeled ‘‘protein coding genes, Alus and other repeats,’’ revealed
that the vast majority of these sequences displayed largely
Figure 4. Location of BDP1, BRF1, and POLR3D peaks on RN5S genes. (A) UCSC Genome Browser
view of the 5S cluster on chromosome 1. (B) Zoom-in on one of the RN5S gene in the cluster. The visual
peak files and the markings are as in the legend of Figure 3.
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coincident BDP1, BRF1, and POLR3Dpeaks or combination thereof,
which often covered broad sequences. Moreover, the BDP1 and
BRF1 peak scores were oftenmuchhigher than the POLR3D scores,
in contrast to what we observe for most bona fide Pol III tran-
scription units. We consider, therefore, that these peaks are prob-
ably artifacts and do not correspond to actively transcribed, bona
fide Pol III transcription units. There were, however, a few excep-
tions, which are listed in Supplemental Table S5 (rows 44–50,
highlighted in turquoise). Figure 6 and Supplemental Figure S2
show the five most convincing examples. RP3TR1, TRNAAL1,
a tRNA-derived sequence, and RP3TR2 contained BDP1, BRF1, and
POLR3D peaks (Fig. 6A), whereas POLR3E and MIRb-SINE-MIR
contained only BRF1 and POLR3D peaks (Supplemental Fig. S2A).
In all cases, the sequence covered by the POLR3D peak contains A
and B boxes as well as a run of T residues, as shown in Figures 6B
and Supplemental Figure S2B. Figure 6C and Supplemental Figure
S2C show transcriptions in vitro performed with genomic frag-
ments containing the RP3TR1, RP3TR2, POLR3E, and MIRb-SINE-
MIR sequences, as well as with the control Ad2 VAI gene fragment.
In all cases, we obtained RNAs of the expected size and expected
tagetin sensitivity. The POLR3E and MIRb-SINE-MIR sequences
gave each two RNA products, which may correspond to termina-
tion at different runs of T residues (Supplemental Fig. S2C). We
tested expression in vivo by Northern blot, as shown in Figure 6D.
We could detect expression of TRNAAL1, the tRNA-derived gene
(lanes 3, 4), as well as of RP3TR1 (lanes 1, 2). In the latter case, we
detected two signals, the slower migrating one consistent with
a transcript length corresponding to the POLR3D peak width and
the shorter one apparently a spliced form of the first, lacking
a short internal region (data not shown). We also detected weak
Northern blot RNA signals for the POLR3E and MIRb-SINE-MIR
loci, but not for RP3TR2, suggesting that in the latter case the RNA
produced is unstable (data not shown).Wedidnot further examine
the two remaining putative new Pol III transcription units in
Supplemental Table S5 (rows 47, 49). These results reveal active Pol
III transcription of a microRNA gene, as well as novel Pol III genes
in exponentially growing IMR90h Tert cells.
SNAPC2 occupancy marks type 3 Pol III genes
As shown in Figure 1, the type 3 RNU6 promoter recruits SNAPc
and BRF2–TFIIIB instead of TFIIIC and BRF1–TFIIIB. It seemed
thus likely that sequences displaying POLR3D and BDP1 peaks,
but no BRF1 peaks, might correspond to genes with type 3 pro-
moters. To help us identify such genes, we performed ChAPs
with the IMR90hTert cell line expressing tagged SNAPC2. Here, we
describe the SNAPC2 peaks in close proximity to POLR3D peaks.
We obtained 35 such peaks, of which 25 were completely over-
lapping with POLR3D peaks and thus unlikely to mark true Pol III
transcription units. We eliminated another two because they
lacked a run of at least four T residues at the end of the POLR3D
peak. Of the remaining eight, none had close-by BRF1 peaks, as
expected for type 3 promoter genes, and six had BDP1 peaks.
Supplemental Table S6, rows 1–8, lists the corresponding genomic
locations, as well as two additional genomic locations (rows 9, 10)
displaying offset BDP1 and POLR3D peaks, a run of T residues at
the end of the POLR3D peak, but neither BRF1 nor SNAPC2 peaks.
These locations all corresponded to known genes, namely the
TRNAU1 (tRNASeC(e) TCA), the RNU6 snRNA, the RNU6ATAC, the
RN7SK, the RMRP, the RPPH1, and the RNY1 (hY1) and RNY3 (hY3)
genes.
As shown in Supplemental Table S3, only one of three human
selenocysteine tRNA genes seemed transcribed (see rows 138, 267,
and 496) with POLR3D and BDP1, but no BRF1, peaks. Seleno-
cysteine tRNAgenes contain a PSE, a TATA box, and a gene-internal
B box, but transcription in vitro does not require the A and B box
binding factor TFIIIC (Meissner et al. 1994). The observed binding
of SNAPC2, but not BRF1, in vivo confirms that the PSE and TATA
box are the functional elements, and thus that the selenocysteine
tRNA gene has a functional type 3 promoter.
The human genome contains at least nine, dispersed, full-
length RNU6 loci (Domitrovich and Kunkel 2003). Out of these,
four (U6-3 to U6-6) lack 59 promoter elements, and, indeed, U6-4 is
not expressed in transfection experiments. In contrast, all others
have aDSE, a PSE, and a TATAbox and are expressed in transfection
Figure 5. The MIR886 gene is transcribed by Pol III. (A) UCSC Genome
Browser view of the MIR886 microRNA. The visual peak files and the
markings are as in the legend of Figure 3. (B) The sequence corresponding
to the POLR3D peak region (on theminus strand) is shownwith putative A
and B boxes indicated (the underlined nucleotides fit the A and B box
consensus defined in Supplemental Fig. S1A). The likely transcription start
and termination sites, as determined by POLR3D occupancy and se-
quence, are indicated. (C ) The MIR886 gene is transcribed by Pol III in
vitro. The genomic fragment carrying the MIR886 locus was immobilized
on beads and used as template for in vitro transcription as described in
Supplemental material. Tagetin was added in the reactions shown in lanes
2 and 4. The control template was the Ad2 VAI gene. (D) Pre-MIR886 RNA
can be detected by Northern blot in IMR90hTert cells. Lanes 1 and 2 show
duplicate RNA preparations. The blot was probed with a complementary
oligonucleotide corresponding to regions 49–69 and 93–112 of the
microRNA gene MIR886.
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experiments, albeit at different levels (Domitrovich and Kunkel
2003; data not shown). We found BDP1, SNAPC2, and POLR3D
peaks on RNU6 (U6-8) and RNU6 (U6-9) (Supplemental Table S6,
rows 2, 3), and POLR3D and SNAPC2 on RNU6 (U6-2) (Supple-
mental Table S6, row4). RNU6 (U6-1), an snRNAgene that has been
intensively studied (for review, see Hernandez 2001; Jawdekar and
Henry 2008), had surprisingly only a POLR3D peak (peak score
138), and so did RNU6 (U6-7) (peak score 16) (see below; Supple-
mental Table S7, rows 3, 4). This suggests that three RNU6 snRNA
genes are highly transcribed in IMR90hTert cells, with a fourth one
(U6-1) transcribed at a lower level and a fifth one (U6-7) transcribed
at a very low level.
The RNU6ATAC snRNA is part of the minor U12-type spli-
ceosomal complex involved in splicing of a rare class of in-
trons (the AT–AC introns) (see Lorkovic et al. 2005, references
therein). We observed BDP1, POLR3D, and SNAPC2 peaks on
a single RNU6ATAC sequence, indicating a type 3 promoter and
consistent with the report that there is only one true RNU6ATAC
gene in the human genome (Marz et al. 2008). Similarly, we
detected SNAPC2, BDP1, and POLR3D on single RN7SK and RMRP
sequences, and SNAPC2 and POLR3D on an RPPH1 sequence,
consistent with previous reports indicating single true genes with
type 3 promoters (Kruger and Benecke 1987; Murphy et al. 1987;
Baer et al. 1990; Hannon et al. 1991; Yuan and Reddy 1991).
The Y RNAs associate with the Ro autoantigen to form Ro
particles, which have been implicated in UV light resistance and
other functions (see Perreault et al. 2007). There are four human
Y genes, RNY1 (hY1), RNY3 (hY3), RNY4 (hY4), and RNY5 (hY5)
(corresponding toMIR1975, see below), all located on a 50,000-bp
region on chromosome 7, and all with type 3 promoters (Wolin
and Steitz 1983; Maraia et al. 1994; Maraia et al. 1996). RNY3 and
RNY1 code for the longest Y RNAs, whereas RNY4 and RNY5 code
for shorter forms. All genes are reported expressed in human cells
(Pruijn et al. 1993). We observed BDP1 and POLR3D on the RNY1
Figure 6. Examples of three novel Pol III transcription units. (A) UCSC Genome Browser views of three putative new Pol III transcription units (RP3TR1,
RP3TR2, and TRNAAL1). The visual peak files and the markings are as in the legend of Figure 3. (B) The sequences corresponding to the POLR3D peak
regions (on theminus strand for RP3TR1 and TRNAAL1, and on the plus strand for RP3TR2) are shown. Themarkings on the sequence are as in the legend of
Figure 3. (C ) RP3TR1 and RP3TR2 are transcribed by Pol III in vitro. Genomic fragments carrying the RP3TR1 and RP3TR2 loci were immobilized on beads
and used as template for in vitro transcription as described in the Supplementalmaterial. Tagetin was added in the reactions shown in lanes 2, 4, and 6. The
control template was the Ad2 VAI gene. (D) RP3TR1 and TRNAAL1 RNAs can be detected by Northern blot in IMR90hTert cells. Lanes 1–2 and 3–4 show
duplicate RNA preparations. For RP3TR1, the blot was probed with complementary oligonucleotides corresponding to regions 208–237 or 303–328 of the
putative gene. For TRNAAL1, the oligonucleotides corresponded to regions 23–46 and 51–71.
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and RNY3 genes, and POLR3D peaks only on RNY4 and RNY5 (see
below; Supplemental Table S7), suggesting that these last two
genes are only weakly expressed.
Figure 7 shows the location of the SNAPC2, BDP1, and
POLR3D peaks on the TRNAU1 [tRNASeC(e) TCA] and the
RNU6ATAC genes. The SNAPC2 peak is well upstreamof the TSS, in
fact, for all the genes in Supplemental Table S6, the SNAPC2 peak
is upstream of the PSE, which is located approximately between
positions50 and68. Crosslinking experiments suggest that the
PSE is bound by the SNAPC4 (SNAP190) and SNAPC3 (SNAP50)
subunits of SNAPc. These results suggest that SNAPC2, which as-
sociates with the C terminus of SNAPC4 (SNAP190), is located at
the ‘‘back’’ of the complex, away from the transcription start site.
In contrast, the BDP1 peak is much closer to the TSS.
POLR3D-only peaks
As discussed above, we chose to focus on combinations of peaks to
investigate the extent of the known Pol III transcription machin-
ery in human cells. However, bymaking this choice wemight have
discarded bona fide Pol III genes that are weakly expressed or genes
whose expression is dependent on unknown transcription factors.
To explore these possibilities, we examined the POLR3D peaks
lacking neighboring BDP1, BRF1, or SNAPC2 peaks (and not cor-
responding to tRNA genes). We eliminated those peaks that (1)
overlapped sequences containing runs of Ts on either strand, and
(2) lacked runs of Ts within a 50-bp window on either side (see
Methods). We also eliminated peaks with POLR3D scores smaller
than 10 or with shapes never observed on known Pol III tran-
scription units. Supplemental Table S7 lists the remaining peaks.
Among them are four known genes alreadymentioned above (two
RNU6 genes, the RNY4 and RNY5 genes). The rest are candidates for
novel Pol III genes. To confirm that at least some of these candidate
novel genes can in fact serve as Pol III templates, we amplified
genomic fragments containing three of them, namely AluJb-SINE-
Alu, HuERSP-P1-LTR-ERV1, and MIR-SINE-MIR (rows 13, 18, 69),
and used them for transcription in vitro. As shown in Supplemental
Figure S3, all three fragments generated RNAs of the expected size
and sensitivity to tagetin, consistent with these three loci indeed
containing actively transcribed Pol III genes. Moreover, we could
detect the expression of AluJb-SINE-Alu in vivo by Northern blot
analysis (data not shown). Thus, the three genes fromSupplemental
Table S7 that we tested are, in fact, actively transcribed, suggesting
that several additional candidates listed in Supplemental Table S7
also represent bona fide Pol III transcription units.
Discussion
We have mapped BDP1, BRF1, SNAPC2, and Pol III chromatin
occupancy in dividing human IMR90hTert cells by ChIP-seq. To
deal with the repeated nature of many Pol III transcription units,
we developed an analysis method that takes into account repeated
tags. This method can be used to study any genes rich in repeated
sequences such as, for example, the Pol II snRNA genes. Rather
than eliminating peaks with stringent quantitative filters, as is
commonly done in ChIP-seq analyses, we chose to focus on
combinations of peaks consisting of POLR3D and at least one of
the transcription factors examined, BDP1, BRF1, or SNAPC2,
reasoning that such combinations were likely to correspond to
bona fide Pol III transcription units. Indeed, examination of factor
occupancy on all tRNA sequences revealed that genes with high
score POLR3D peaks also harbored BDP1 and BRF1 peaks. As the
POLR3D scores diminished, absence of BDP1 or BRF1 peaks be-
came more frequent, with the BDP1 peaks getting lost more
quickly than the BRF1 peaks. Importantly, the POLR3Dpeak scores
are likely to reflect transcription efficiency, as in at least the few
cases directly examined, genes with high POLR3D peak scores
consistently produced more RNA than genes with lower POLR3D
occupancy. Thus, the POLR3D ChIPs appear the most sensitive,
followed by the BRF1, and then the BDP1, ChIPs. (Because the
number of Pol III genes with SNAPC2 peaks is small, it is difficult to
assess the relative sensitivity of the SNAPC2 ChAP.)
Figure 7. Location of BDP1, SNAPC2, and POLR3D peaks on the TRNAU1 (tRNA-SeC) and RNU6ATAC genes. UCSCGenome Browser views showing the
BDP1, SNAPC2, and POLR3D peaks, as well as the unique tag coverage indicating the regions spanned by tags unique within the BDP1, SNAPC2, and
POLR3Dpeaks, respectively. The POLR3D, BDP1, and SNAPC2 visual peak tracks were generated as described in the legend to Figure 3. (A) TRNAU1 (tRNA-
SeC ) gene. (B) RNU6 snRNA gene.
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Examination of tRNA genes revealed that the BDP1 and BRF1
peaks were consistently located upstream of the POLR3D peak,
indeed this was true for all known genes with type 1 and 2 pro-
moters and for BDP1 and SNAPC2 on type 3 promoters. Moreover,
we found that SNAPC2 was consistently localized upstream of the
PSE, whereas previous results have localized SNAPC4 (SNAP190)
on the PSE (for review, see Hernandez 2001). This is a remarkable
observation, as it indicates that the ChIP-seq method has a reso-
lution high enough to identify different protein–DNA contacts
within a complex, and to localize various subunits relative to the
DNA. Thus, the ChIP-seq method can be used to dissect, in vivo,
protein-DNA contacts between the subunits of a complex onDNA.
Here, we used the spatial information as an added criterion to
eliminate many peak combinations in which the peaks were
completely or largely overlapping. Moreover, we asked that puta-
tive Pol III terminators be located at positions compatible with Pol
III transcription. As a result, we suspect that there are few false-
positives in our analysis.
As we focused our analysis on genomic locations with com-
binations of POLR3D and at least one of the known Pol III tran-
scription factors, we selected, in effect, for genomic sites with
combinations of factors resembling those found on the Pol III
model promoters studied so far. It is remarkable that the over-
whelming majority of the genomic sites carrying such combina-
tions of factors ended up corresponding to genes known to be
transcribed by Pol III. This suggests that the known basal Pol III
machinery is used very broadly in actively dividing culture cells.
We can now address whether this machinery is also used in dif-
ferentiated, nondividing cells. Indeed, the basal Pol II machinery
seems to undergo major changes in some differentiated cells with
replacement of the TFIID complex by another complex containing
TAF3 (Deato and Tjian 2007; Deato et al. 2008) (but not TRF3/
TBP2, as originally reported [see Gazdag et al. 2009]), raising the
possibility of similarmajor changes in the basalmachinery used by
other RNA polymerases. We can also address how Pol III occu-
pancy, and thus transcription, varies in different cellular states.We
observe, for example, that a large proportion of tRNA genes is
poorly or not occupied by POLR3D in dividing IMR90hTert cells.
Although the highly POLR3D-occupied tRNA genes have slightly
different A and B boxes than tRNA genes with no POLR3D, there is
no good correlation between A and B box scores and POLR3D
occupancy, suggesting that other factors regulate these genes. In-
deed, tissue-specific differences in human tRNA gene expression
have been documented (Dittmar et al. 2006). More generally, Pol
III transcription in mammalian cells is known to be regulated with
cell growth and proliferation by factors such as RB1 (Rb), RBL1
(p107), NOLC1 (p130), TP53, MYC, and MAF1 (for review, see
White 2005, 2008; Goodfellow and White 2007). The approach
described will allow a global view of the Pol III transcriptome
variations with cellular identity and state.
Besides broad use of the basal Pol III transcriptionmachinery,
our results reveal that the Pol III transcriptome in actively dividing
IMR90hTert cells is only slightly larger than previously suspected,
even though we cannot exclude that we are missing weakly
transcribed Pol III genes. We were surprised to find that none of
themicroRNAgenes describedpreviously as being transcribedbyPol
III harbored BDP1, BRF1, SNAPC2, or POLR3D peaks. Rather, we
found that several of the reported microRNA gene genomic posi-
tions correspond, in fact, to tRNA genes. Similarly, we checked the
genomic locations with putative type 3 promoters (Pagano et al.
2007), but all were negative. On the other hand, we identified
a clear Pol III transcribed microRNA,MIR886. Moreover, the RNY5
gene, which has an isolated, but very convincing POLR3D peak,
overlaps with MIR1975 (hsa-mir-1975), strongly suggesting that
this second microRNA is also produced by Pol III. Eight additional
genomic locations, one, TRNAAL1, annotated as tRNA-derived,
and the rest with various annotations (Supplemental Tables S5, S7,
rows labeled orange in the first column) contain active Pol III
transcription units as determined by in vitro transcription and/or
Northern blot. Interestingly, of the eight confirmed as actively
transcribed genes, three (RP3TR2, AluJb-SINE-Alu, and MIR-SINE-
MIR) are locatedwithin introns of Pol II transcription units and are
transcribed on the opposite strand as the Pol II gene. This raises the
possibility that they perform a regulatory function, either at the
level of transcription itself, perhaps by reducing the efficiency of
Pol II transcription on the other strand, or through an action of
their RNA products, which may hybridize to the corresponding
pre-mRNA or act at the chromatin level. Another few dozen are
likely candidates (Supplemental Table S5, rows 47, 49; Table S7).
Thus, there are some 350 tRNA genes (genes in groups 1 and 2 and
some in group 3) and ;130 other genes (genes in Supplemental
Tables S5–S7) actively transcribed in dividing IMR90hTert cells.
This last group includes a few dozen candidate new Pol III genes, of
which we have confirmed nine, notably a microRNA gene, as well as
eight genes of unknown function, as novel Pol III transcription units.
Methods
ChIPs
The large scale ChIPs were performed with 5 3 107 million sub-
confluent IMR90 cells transfected with the human telomerase
reverse transcriptase gene (a gift of Greg Hannon, Cold Spring
Harbor Laboratory), essentially as described by O’Geen et al.
(2006). Minor modifications are detailed in the Supplemental
material.
ChAPs
ChAPswere performedwith IMR90HTert stable cell line expressing
human SNAPC2 fused to the Tobacco etch virus (TEV), the Flag
epitope, and the biotin acceptor domain (BAD). The detailed pro-
tocol is included the Supplemental material.
Mapping of sequence tags onto the unmasked human genome
The DNA material from the ChIPs was submitted to high-
throughput sequencing and sequence tagswere generatedwith the
Bustard (Illumina) base caller protocol. The mean size of the frag-
ments sequenced was 115 for POLR3D, 92 for BDP1, 78 for BRF1,
and 130 for SNAPC2 ChIPs or ChAPs. The methods used to align
tags onto the genome, detect peaks, and quantify peaks are de-
tailed in the Supplemental material.
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